Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ann-Katrin Exeli"'
Autor:
Linda Agolli, Luca Nicosia, Thomas Hilger, Gheorghe Iancu, Ann-Katrin Exeli, Bastian Eul, Tobias Struffert, Till Acker, Daniel Habermehl
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Background We retrospectively investigate feasibility and safety of whole brain radiotherapy (WBRT) including a simultaneous-integrated boost technique (WBRT-SIB) in a cohort of patients with a very poor prognosis suffering from multiple and
Externí odkaz:
https://doaj.org/article/65d07741e2b54da3ae4e7f8578d49819
Autor:
Ann-Katrin Exeli, Daniel Kellner, Lukas Exeli, Phil Steininger, Frank Wolf, Felix Sedlmayer, Heinz Deutschmann
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-8 (2018)
Abstract Background To date, patients with glioblastoma still have a bad median overall survival rate despite radiation dose-escalation and combined modality treatment. Neurocognitive decline is a crucial adverse event which may be linked to high dos
Externí odkaz:
https://doaj.org/article/0a3e515f950a480fbb590db492283687
Autor:
Lukas Exeli, Ann-Katrin Exeli, Felix Sedlmayer, Phil Steininger, Frank Wolf, Heinz Deutschmann, Daniel Kellner
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 13, Iss 1, Pp 1-8 (2018)
Radiation Oncology, Vol 13, Iss 1, Pp 1-8 (2018)
Background To date, patients with glioblastoma still have a bad median overall survival rate despite radiation dose-escalation and combined modality treatment. Neurocognitive decline is a crucial adverse event which may be linked to high doses to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eae681c44e993bace18afb6659a8fed4
https://pubmed.ncbi.nlm.nih.gov/29409516
https://pubmed.ncbi.nlm.nih.gov/29409516
Autor:
Heinz Deutschmann, Birgit Maurer, Karin Dagn, Michael Studnicka, Felix Sedlmayer, Peter Kopp, Ann-Katrin Exeli, Franz Zehentmayr, Karl Wurstbauer, Peter Porsch
Publikováno v:
Strahlentherapie Und Onkologie
Background To report acute and late toxicity with long-term follow-up, and to describe our experiences with pulmonary dose constraints. Methods Between 2002 and 2009, 150 patients with 155 histologically/cytologically proven non-small cell lung cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e57df82ddc61ea01ff60d3d452a5e36
https://pubmed.ncbi.nlm.nih.gov/28116446
https://pubmed.ncbi.nlm.nih.gov/28116446
Autor:
Matthias Söhn, Gerd Fastner, Michael Studnicka, Almut Tröller, Felix Sedlmayer, Heinz Deutschmann, Manfred Kranzinger, Claus Belka, P. Steininger, Franz Zehentmayr, Karl Wurstbauer, Ann-Katrin Exeli, Christoph Fussl
Publikováno v:
Radiation Oncology (London, England)
Background One of the primary dose-limiting toxicities during thoracic irradiation is acute esophagitis (AE). The aim of this study is to investigate dosimetric and clinical predictors for AE grade ≥ 2 in patients treated with accelerated radiother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11363cb1cd286ffeb4c063fbea91b8ff
Autor:
Matthias Söhn, A. Tröller, Felix Sedlmayer, Ann-Katrin Exeli, Christoph Fussl, Karl Wurstbauer, Michael Studnicka, Gerd Fastner, Claus Belka, Franz Zehentmayr
Publikováno v:
Radiotherapy and Oncology. :S630
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de62db0bed1d2a19cfdd2d30546722b